Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorKNOBLER, Robert
dc.contributor.authorGEROLDINGER-SIMIĆ, Marija
dc.contributor.authorKREUTER, Alexander
dc.contributor.authorHUNZELMANN, Nicolas
dc.contributor.authorMOINZADEH, Pia
dc.contributor.authorRONGIOLETTI, Franco
dc.contributor.authorDENTON, Christopher
dc.contributor.authorMOUTHON, Luc
dc.contributor.authorCUTOLO, Maurizio
dc.contributor.authorSMITH, Vanessa
dc.contributor.authorGABRIELLI, Armando
dc.contributor.authorBAGOT, Martine
dc.contributor.authorOLESEN, Anne B.
dc.contributor.authorFOELDVARI, Ivan
dc.contributor.authorJALILI, Ahmad
dc.contributor.authorKÄHÄRI, Veli Matti
dc.contributor.authorKÁRPÁTI, Sarolta
dc.contributor.authorKOFOED, Kristian
dc.contributor.authorOLSZEWSKA, Malgorzata
dc.contributor.authorPANELIUS, Jaana
dc.contributor.authorQUAGLINO, Pietro
hal.structure.identifierImmunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
dc.contributor.authorSENESCHAL, Julien
dc.contributor.authorSTICHERLING, Michael
dc.contributor.authorSUNDERKÖTTER, Cord
dc.contributor.authorTANEW, Adrian
dc.contributor.authorWOLF, Peter
dc.contributor.authorWORM, Margitta
dc.contributor.authorSKROK, Anna
dc.contributor.authorRUDNICKA, Lidia
dc.contributor.authorKRIEG, Thomas
dc.date.accessioned2024-11-13T13:24:29Z
dc.date.available2024-11-13T13:24:29Z
dc.date.issued2024-03
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/203235
dc.description.abstractEnThe term ‘sclerosing diseases of the skin’ comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement and can sometimes be difficult to distinguish from each other. The present consensus provides an update to the 2017 European Dermatology Forum Guidelines, focusing on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis. In addition, updated strategies for the first- and advanced-line therapy of sclerosing skin diseases are addressed in detail. Part 2 of this consensus provides clinicians with an overview of the diagnosis and treatment of scleromyxoedema and scleroedema (of Buschke).
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.title.enConsensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema
dc.typeArticle de revueen_US
dc.identifier.doi10.1111/jdv.19937en_US
dc.subject.halSciences du Vivant [q-bio]/Immunologieen_US
dc.identifier.pubmed38456518en_US
bordeaux.journalJournal of the European Academy of Dermatology and Venereologyen_US
bordeaux.page1281 – 1299en_US
bordeaux.volume38en_US
bordeaux.hal.laboratoriesImmunoConcEpT - UMR 5164en_US
bordeaux.issue7en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-04780512
hal.version1
hal.date.transferred2024-11-13T13:24:36Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccCC BY-NCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.date=2024-03&rft.volume=38&rft.issue=7&rft.spage=1281%20%E2%80%93%201299&rft.epage=1281%20%E2%80%93%201299&rft.au=KNOBLER,%20Robert&GEROLDINGER-SIMI%C4%86,%20Marija&KREUTER,%20Alexander&HUNZELMANN,%20Nicolas&MOINZADEH,%20Pia&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée